mean platelet volume
[대역어] 평균혈소판용적
[용어속성] Term
[용어속성] Term
Platelets and renal failure in the SARS-CoV-2 syndrome
SARS-CoV-2 증후군의 혈소판 및 신부전
Article
[키워드] ACE
ACE2
ACE2 receptor
ACE2 receptors
activated
Acute kidney injury
acute respiratory syndrome
AKI
C reactive protein
caused
cleavage
Cohort
coronavirus
coronavirus disease
correlation
COVID-19
COVID-19 disease
COVID19 patients
Critically ill
CRP
D-dimer
D-dimer level
disease
elevated
etiology
facilitate
feature
ferritin
GFR
glomerular filtration rate
granular
Host
human cells
hypercoagulability
hypercoagulable
incidence
Interaction
lactate dehydrogenase
LDH
mean platelet volume
modulation
MPV
negative correlation
patients
Platelet
protease
receptor
renal
renal failure
Respiratory failure
SARS-CoV-2
syndrome
the SARS-CoV-2
unique
viral infection
viral spike protein
Volume
with COVID-19
[DOI] 10.1080/09537104.2020.1817361 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/09537104.2020.1817361 PMC 바로가기 [Article Type] Article
Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection
SARS-CoV-2 감염 환자의 혈액학적 매개변수와 질병 중증도 간의 연관성
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Admission
Analysis
analyzed
association
Biomarker
Biomarkers
Blood cells
calculated
caused
characteristic
characterized
complement
coronavirus
coronavirus disease
diagnostic
disease
disease severity
distribution
Health crisis
hematological parameter
hematological parameters
hematological parameters.
high risk
highest
identify
independent
Infection
Inflammatory responses
lymphocyte
Lymphocyte count
marker
mean platelet volume
measure
Mild disease
mild illness
moderate
monocyte
Multivariate analysis
neutrophil
neutrophil counts
Neutrophil-to-lymphocyte ratio
NLR
Novel coronavirus
novel coronavirus disease
Older age
parameter
parameters
Patient
patients with SARS-CoV-2
Platelet
Platelet count
Predictive
predictive values
progression
public health crisis
receiver
receiver operating characteristic
Red cell
regression analysis
respiratory
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe disease
Spread
subpopulations
Univariate analysis
Volume
WBC
WBCs
were used
White blood cell
White blood cells
with mild disease
[DOI] 10.1002/jcla.23604 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/jcla.23604 PMC 바로가기 [Article Type] Article
COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study
COVID-19 질병 - 질병 경과에 따른 완전한 혈구 수 매개변수의 시간적 분석, 생존자 및 비생존자의 환자 인구 통계 및 관리 결과와의 관계: 종단적 기술 코호트 연구
Research Article
[키워드] 95% CI
95%CI
Acute inflammation
age
analysed
Analysis
anisocytosis
ANOVA
average
Biomarkers
Blood
blood cell
blood cell count
blood count
cardiovascular disease
cardiovascular diseases
carried
CBC
Cell
chronic renal failure
Clinical outcome
co-morbidities
co-morbidity
cohort study
Complete
complete blood count
Concentration
confounding effect
continuous variable
continuous variables
COPD
Course
COVID-19
COVID-19 disease
COVID-19 patient
COVID19
death
demographics
diabetes
disease
distribution
enrolled
estimates
Evolution
Gender
Haemoglobin
identify
Increased
Infectious diseases
Inpatient
Inpatients
Italian
Italy
joint
later phase
longitudinal cohort study
lymphocyte
lymphocyte counts
Lymphocytes
management
mean platelet volume
measure
median
Monocytes
morbidities
neutrophil
neutrophil counts
Neutrophils
non-survivor
Non-survivors
obesity
outcome
p-values
parameter
parameters
Patient
patient age
patients with diabete
performed
Platelet
Platelets
prognostic
prognostic indicator
red blood cell
red blood cell count
reduced
renal
renal failure
Rome
significantly
significantly higher
Stata
statistical
survivor
Symptoms
Volume
with COVID-19
[DOI] 10.1371/journal.pone.0244129 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0244129 PMC 바로가기 [Article Type] Research Article
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19
COVID-19 성인 입원 환자의 생존자와 비생존자의 실험실 마커의 시간적 변화
Comparative Study
[키워드] acidity
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
albumin
albumin-globulin ratio
alkaline phosphatase
Analysis
aspartate
Aspartate aminotransferase
base excess
Bicarbonate
Blood
blood cell
blood cell count
C-reactive protein
calcium
carbon dioxide
caused
Cell
changes
changes in
cholesterol
cholinesterase
Clinical characteristics
clinician
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
creatine
creatine kinase
cystatin C
D-dimer
death
Degradation
Degradation product
determine
diagnosed with COVID-19
distribution
eosinophil
Eosinophil count
estimated glomerular filtration rate
Extracellular
Extracellular fluid
FIBRIN
filtration rate
fluorescent
fraction
glomerular filtration rate
Glucose
Haemoglobin
high risk
High-density lipoprotein
High-density lipoprotein cholesterol
Hospitalized
hypersensitive C-reactive protein
immature
Inpatient
International
international normalized ratio
Laboratory
Laboratory test
Laboratory tests
Lactate
lactate dehydrogenase
lipoprotein cholesterol
lymphocyte
Lymphocyte count
Magnesium
marker
mean platelet volume
Mild
monocyte
Myoglobin
neutrophil
neutrophil count
nitrogen
non-survivor
Non-survivors
normalized
occurred
ogen
outbreak
Patient
patient condition
phosphatase
phosphorus
plasma
plasma urea
Platelet
Platelet count
platelet distribution width
prealbumin
procalcitonin
progression
Protein
prothrombin
Prothrombin time
red blood cell
red blood cell count
Result
SARS-CoV − 2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe disease
significant difference
significant differences
significantly
significantly increased
sodium
supplementary material
survivor
Temporal
Temporal changes
test results
total calcium
Total cholesterol
total protein
Treatment
Triglyceride
urea
urea nitrogen
uric acid
variable
variables
Volume
White blood cell
white blood cell count
width
with COVID-19
Wuhan
[DOI] 10.1186/s12879-020-05678-0 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1186/s12879-020-05678-0 PMC 바로가기 [Article Type] Comparative Study